ACET
Adicet Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$66.24M
P/E Ratio
—
EPS
$-16.95
Beta
1.58
52W High
$17.44
52W Low
$6.01
50-Day MA
$7.26
200-Day MA
$10.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.82
About Adicet Bio Inc
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $24.99M |
| EBITDA | $-115.73M |
| Operating Margin | 0.00% |
| Return on Equity | -67.50% |
| Return on Assets | -37.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $14.82 |
| Price-to-Book | 0.42 |
| Price-to-Sales (TTM) | 9.72 |
| EV/Revenue | 2.139 |
| EV/EBITDA | -1.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $9.60M |
| Float | $6.85M |
| % Insiders | 0.90% |
| % Institutions | 69.69% |
Analyst Ratings
Consensus ($53.00 target)
7
BuyData last updated: 4/7/2026